INS and type 2 diabetes mellitus: Similar observations have been reported in non-critically ill patients with type II diabetes mellitus, in whom the level of HOMA-insulin resistance index (HOMA-IR) in the insulin-glargine group was significantly lower than that observed in the standard-care group [9].